Approval · Notice of Compliance 20296 · 2018
TREANDA: Notice of Compliance 20296
Issued January 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20296
- Date
- January 10, 2018
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
Medicinal ingredients
- BENDAMUSTINE HYDROCHLORIDE 25 MG per VIAL
- BENDAMUSTINE HYDROCHLORIDE 100 MG per VIAL